http://www.unboundmedicine.com/medline/ebm/research/alemtuzumabUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19892769/full_citation/Comment_on_alemtuzumab_and_inclusion_body_myositis_Greenberg SA 
Comment on alemtuzumab and inclusion body myositis. [JOURNAL ARTICLE]
Brain 2009 Nov 5.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19892767/full_citation/Reply_to:_Comment_on_alemtuzumab_and_inclusion_body_myositis_Dalakas MC, Rakocevic G, Schmidt J, et al. 
Reply to: Comment on alemtuzumab and inclusion body myositis. [JOURNAL ARTICLE]
Brain 2009 Nov 5.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19889126/full_citation/Alemtuzumab_Induction_Prior_to_Cardiac_Transplantation_with_Lower_Intensity_Maintenance_Immunosuppression:_One_Year_Outcomes_Teuteberg JJ, Shullo MA, Zomak R, et al. 
Alemtuzumab Induction Prior to Cardiac Transplantation with Lower Intensity Maintenance Immunosuppression: One-Year Outcomes. [JOURNAL ARTICLE]
Am J Transplant 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19878629/full_citation/Spotlight_on_alemtuzumab_Jones J, Coles A 
Spotlight on alemtuzumab. [Journal Article]
Int MS J 2009 Sep; 16(3):77-81.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19874308/full_citation/Severe_liver_dysfunction_from_hepatitis_C_virus_reactivation_following_alemtuzumab_treatment_for_chronic_lymphocytic_leukaemia_Anoop P, Wotherspoon A, Matutes E 
Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia. [JOURNAL ARTICLE]
Br J Haematol 2009 Oct 28.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19863336/full_citation/Fludarabine_followed_by_alemtuzumab_consolidation_for_previously_untreated_chronic_lymphocytic_leukemia:_final_report_of_Cancer_and_Leukemia_Group_B_study_19901_Byrd JC, Byrd JC, Peterson BL, et al. 
Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901. [Journal Article]
Leuk Lymphoma 2009 Oct; 50(10):1589-96.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19860617/full_citation/Alemtuzumab_for_relapsed_and_refractory_erythrodermic_cutaneous_T_cell_lymphoma:_a_single_institution_experience_from_the_Robert_H__Lurie_Comprehensive_Cancer_Center_Querfeld C, Mehta N, Rosen ST, et al. 
Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center. [JOURNAL ARTICLE]
Leuk Lymphoma 2009 Oct 8.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19858055/full_citation/Infectious_Complications_in_Patients_With_Chronic_Lymphocytic_Leukemia:_Pathogenesis_Spectrum_of_Infection_and_Approaches_to_Prophylaxis_Morrison VA 
Infectious Complications in Patients With Chronic Lymphocytic Leukemia: Pathogenesis, Spectrum of Infection, and Approaches to Prophylaxis. [JOURNAL ARTICLE]
Clin Lymphoma Myeloma 2009 Oct 1; 9(5):365-370.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19857382/full_citation/New_Immunosuppressive_Agents_and_Risk_for_Invasive_Fungal_Infections_Maschmeyer G, Patterson TF 
New Immunosuppressive Agents and Risk for Invasive Fungal Infections. [JOURNAL ARTICLE]
Curr Infect Dis Rep 2009 Nov; 11(6):435-438.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19857167/full_citation/Fever_Shock_and_Pancytopenia_in_a_Patient_Treated_with_Alemtuzumab_Bauer MP, van Burgel ND, Marijt WA, et al. 
Fever, Shock, and Pancytopenia in a Patient Treated with Alemtuzumab. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Nov 15; 49(10):1540.
Full Citation | Find Related Articles